Moderna's Bullish Moves in Options Trading Revealed
Understanding Recent Options Activity for Moderna
Recently, significant investors have displayed a bullish sentiment towards Moderna. When analyzing the options history for Moderna (MRNA), we observed a total of 14 notable trades. Interestingly, around 57% of investors entered bullish trades, while approximately 35% adopted a bearish outlook.
The breakdown of these trades reveals that among the detected transactions, seven trades involved puts, amounting to $1,135,204, whereas the remaining seven were calls with a total value of $483,749.
Projected Price Targets for Moderna
Analysts suggest that the significant investors are looking for Moderna's stock to reach a price range between $30.0 and $60.0 over the upcoming months. This target is derived from the recent trading behavior observed in the options market.
Current Volume and Open Interest Trends
In the latest trading sessions, the average open interest for Moderna options positions stands at 3,878.9, while the total volume has reached 3,512. The accompanying data illustrates the trend in both call and put option volumes, as well as the open interest for large trades that fall within the specified strike price range over the last 30 days.
Significant Options Trades Overview
Several key trades have been highlighted:
- Trade One: A bearish put trade scheduled for expiration on 10/17/25, with a total trade price of $615.0K and an open interest of 1.9K.
- Trade Two: Another bearish put sweep set to expire on 01/16/26, amounting to $282.0K with an open interest of 13.7K.
- Trade Three: A bullish call sweep expiring on 06/20/25, totaling $134.1K, having an open interest of 4.0K.
- Trade Four: A bullish call sweep aimed at 09/19/25, amounting to $98.9K with an open interest of 6.6K.
- Trade Five: A bullish put trade scheduled for 03/21/25, valued at $96.2K and an open interest of 7.4K.
The Landscape of Moderna
Founded in 2010, Moderna is a pioneering biotech company that made headlines with its groundbreaking mRNA technology. Having gone public in December 2018, the firm quickly gained recognition when its COVID-19 vaccine received authorization in the United States in December 2020. Currently, Moderna boasts an impressive portfolio of 40 mRNA development candidates across various therapeutic fields, including oncology, infectious disease, cardiovascular health, and rare genetic conditions.
Current Market Position for Moderna
- Moderna is currently trading at $30.38, reflecting a drop of -2.28% with a trading volume recorded at 4,492,595.
- The Relative Strength Index (RSI) indicates that the stock may be nearing the oversold territory.
- A forthcoming earnings release is expected in approximately 62 days.
Expert Insights on Moderna
In the past month, four analysts have evaluated Moderna's stock, yielding an average target price of $49.25. Opinions vary widely, with:
- An analyst from UBS maintaining a Buy rating, projecting a target of $78.
- Another from B of A Securities holding an Underperform rating, setting the target at $34.
- An RBC Capital analyst downgrading to Sector Perform with a target of $40.
- Barclays has similarly lowered its rating to Equal-Weight, suggesting a price target of $45.
While options trading can be riskier than straightforward stock trading, the potential for profits is greater. Savvy options traders often mitigate risks through continuous education, careful trade management, and an informed understanding of market indicators.
To stay informed of the latest options transactions related to Moderna, real-time updates and alerts can be accessed through various financial news platforms.
Frequently Asked Questions
1. What is the recent trend in Moderna's options trading?
Recent data shows a predominance of bullish trading activity among investors, with a significant proportion of trades favoring calls over puts.
2. What are the projected price targets for Moderna?
Analysts indicate that significant investors are targeting a stock price range for Moderna between $30.0 and $60.0 in the coming months.
3. How does Moderna's current stock price compare historically?
As of now, Moderna is trading at $30.38, which shows a decrease of -2.28% from previous trading sessions.
4. What is the importance of open interest in options trading?
Open interest represents the total outstanding options contracts. High open interest indicates strong market interest and liquidity in the options market.
5. What are the latest expert opinions on Moderna's stock?
The latest analyst ratings for Moderna present a mixed outlook, with target prices ranging from $34 to $78, suggesting divergent views on its potential performance.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.